DrugPatentWatch Database Preview
Investigational Drug Information for Deoxythymidine
Email this page to a colleague
What is the development status for investigational drug Deoxythymidine?
Deoxythymidine is an investigational drug.
There have been 10 clinical trials for Deoxythymidine.
The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2021.
The most common disease conditions in clinical trials are HIV Infections, Communicable Diseases, and Acquired Immunodeficiency Syndrome. The leading clinical trial sponsors are National Institute of Allergy and Infectious Diseases (NIAID), Bristol-Myers Squibb, and Zogenix, Inc.
There are two hundred and seventy-seven US patents protecting this investigational drug and thirty international patents.
Summary for Deoxythymidine
| US Patents | 277 |
| International Patents | 30,190 |
| US Patent Applications | 4,197 |
| WIPO Patent Applications | 2,833 |
| Japanese Patent Applications | 3 |
| Clinical Trial Progress | Phase 2 (2021-11-01) |
| Vendors | 87 |
Recent Clinical Trials for Deoxythymidine
| Title | Sponsor | Phase |
|---|---|---|
| Preoperative Chemoradiotherapy With CApecitabine and Temozolomide in MGMT Silenced, MSS, Locally Advanced RecTal Cancer | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Phase 2 |
| A Study of the Efficacy and Safety of MT1621 in Thymidine Kinase 2 (TK2) Deficiency (Treatment naïve) | Zogenix, Inc. | Phase 3 |
| A Study of the Efficacy and Safety of MT1621 in Thymidine Kinase 2 (TK2) Deficiency (Treatment naïve) | Modis Therapeutics, Inc. | Phase 3 |
Clinical Trial Summary for Deoxythymidine
Top disease conditions for Deoxythymidine
Top clinical trial sponsors for Deoxythymidine
US Patents for Deoxythymidine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Deoxythymidine | ⤷ Try it Free | Antibody formulations | GENENTECH, INC. (South San Francisco, CA) | ⤷ Try it Free |
| Deoxythymidine | ⤷ Try it Free | Nucleic acid vaccines | ModernaTX, Inc. (Cambridge, MA) | ⤷ Try it Free |
| Deoxythymidine | ⤷ Try it Free | Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease | Axovant Sciences GmbH (Basel, CH) | ⤷ Try it Free |
| Deoxythymidine | ⤷ Try it Free | Multimodal silica-based nanoparticles | ⤷ Try it Free | |
| Deoxythymidine | ⤷ Try it Free | 1H-pyrazolo[3,4-b]pyridines and therapeutic uses thereof | Samumed, LLC (San Diego, CA) | ⤷ Try it Free |
| Deoxythymidine | ⤷ Try it Free | Nicotinic attenuation of CNS inflammation and autoimmunity | Dignity Health (San Francisco, CA) | ⤷ Try it Free |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Deoxythymidine
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Deoxythymidine | China | CN103533955 | 2031-04-13 | ⤷ Try it Free |
| Deoxythymidine | European Patent Office | EP2696894 | 2031-04-13 | ⤷ Try it Free |
| Deoxythymidine | Japan | JP2014511704 | 2031-04-13 | ⤷ Try it Free |
| Deoxythymidine | South Korea | KR20140043340 | 2031-04-13 | ⤷ Try it Free |
| Deoxythymidine | World Intellectual Property Organization (WIPO) | WO2012140127 | 2031-04-13 | ⤷ Try it Free |
| Deoxythymidine | World Intellectual Property Organization (WIPO) | WO2005111240 | 2024-04-30 | ⤷ Try it Free |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
